Literature DB >> 913416

Polypeptide chains of 19-S thyroglobulin from several mammalian species and of porcine 27-S iodoprotein.

C Marriq, M Rolland, S Lissitzky.   

Abstract

Undegraded 19-S thyroglobulin was purified from hog, ox, man, dog, sheep and rat thyroid glands. Sodium dodecylsulfate/ polyacrylamide gel electrophoresis of the reduced proteins showed that all are formed of peptide chains of molecular weight about 330000. Carboxypeptidase A digestion of porcine 19-S thyroglobulin released consecutively two moles of leucine and then two moles of serine, thus offering strong evidence in favour of the idea that the protein is formed of two identical chains. The same C-terminal amino acids were detected in sheep, ox, dog and man thyroglobulins. No N-terminal amino acid was found by appropriate chemical and enzymatic techniques. Porcine 27-S iodoprotein was shown by carboxypeptidase A analysis to be formed of four single-stranded 330000-Mr subunits identical to those constituting the 19-S protein. Identity, both qualitatively and quantitatively, of the peptides obtained by CNBr cleavage of the two proteins as shown by sodium dodecylsulfate/polyacrylamide gel electrophoresis has confirmed this conclusion. Since 19-S and 27-S thyroid iodoproteins are formed of two and four probably identical chains, they must be termed 19-S and 27-S thyroglobulins or alternatively thyroglobulin dimer and tetramer, respectively.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 913416     DOI: 10.1111/j.1432-1033.1977.tb11792.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Anti-human thyroid peroxidase and anti-human thyroglobulin antibodies present no cross-reactivity on recombinant peptides.

Authors:  M Henry; E Zanelli; Y Malthiery
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

2.  Thyroglobulin entering into molecular biology.

Authors:  S Lissitzky
Journal:  J Endocrinol Invest       Date:  1984-02       Impact factor: 4.256

3.  Identification of recombinant plasmids containing DNA sequences derived from the 3' end of ovine thyroglobulin mRNA.

Authors:  J Chebath; Z T Tosta; O Chabaud; M Perricaudet
Journal:  Mol Biol Rep       Date:  1982-04-16       Impact factor: 2.316

4.  The human thyroglobulin gene contains two 15-17 kb introns near its 3'-end.

Authors:  G J van Ommen; A C Arnberg; F Baas; H Brocas; A Sterk; W H Tegelaers; G Vassart; J J de Vijlder
Journal:  Nucleic Acids Res       Date:  1983-04-25       Impact factor: 16.971

5.  Kinetic studies of the localization of aminopeptidase N in monolayer and in follicle-associated cultures of porcine thyroid cells.

Authors:  S Hovsépian; H Feracci; S Maroux; G Fayet
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

6.  Biochemical characterization of native Usher protein complexes from a vesicular subfraction of tracheal epithelial cells.

Authors:  Marisa Zallocchi; Joseph H Sisson; Dominic Cosgrove
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

7.  Significance of thyroglobulin antibodies cross-reactive with thyroperoxidase (TGPO antibodies) in individual patients and immunized mice.

Authors:  J Ruf; M Ferrand; J M Durand-Gorde; C De Micco; P Carayon
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

8.  Structure-function relationship in thyroglobulin: amino acid sequence of two different thyroxine-containing peptides from porcine thyroglobulin.

Authors:  C Marriq; M Rolland; S Lissitzky
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

9.  Specificity of monoclonal antibodies against human thyroglobulin; comparison with autoimmune antibodies.

Authors:  J Ruf; P Carayon; N Sarles-Philip; F Kourilsky; S Lissitzky
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Isolation of insoluble secretory product from bovine thyroid: extracellular storage of thyroglobulin in covalently cross-linked form.

Authors:  V Herzog; U Berndorfer; Y Saber
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.